New: Our Emerging Health Innovators (EHI) Initiative aims to gain valuable insights on health care gaps. Let’s create health solutions together! EHI Initiative offers two tracks: 🔬Technology-Driven Innovation for early-career investigators 🤝 Community-Centered Innovation for community innovators. Both are paving the way for impactful health solutions!

Global Health challenges require innovative approaches and new ways of ensuring equitable access. Check out Solvandria Foundation for the latest in global health acceleration!

A Call to Action for Global Health Equity 🌎 Recent WHO findings spotlight significant disparities in health research funding and resources across economies, underscoring a critical global challenge. Low- and middle-income nations face notable shortages, with only 0.2% of all health research funding reaching these regions. This stark imbalance highlights an urgent need for a balanced approach to health R&D. What surprises us at Solvandria Foundation is not just the scale of these disparities, but how persistently they undermine global health progress. We are stepping into this arena with a focused mission: 1. 𝐀𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡: Aiming to catalyze the journey of health innovations from concept to real-world applications, we foster partnerships and support projects with the potential to impact global health. 2. 𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐅𝐮𝐭𝐮𝐫𝐞 𝐂𝐡𝐚𝐧𝐠𝐞𝐦𝐚𝐤𝐞𝐫𝐬: Recognizing the power of knowledge, we're committed to creating educational pathways for aspiring health researchers, contributing to a more inclusive research community. We invite researchers, institutions, and supporters who are passionate about making a tangible difference in global health to follow our story. Together, we can bridge the disparities in health research and development, paving the way for innovations that benefit all of humanity, regardless of geographic location or economic status. 𝐉𝐨𝐢𝐧 𝐭𝐡𝐞 𝐦𝐢𝐬𝐬𝐢𝐨𝐧: Follow Solvandria Foundation and send us a message to learn more about how you can get involved. #GlobalHealth #SolvandriaFoundation #HealthInnovation #ResearchForAll 𝐋𝐢𝐧𝐤 𝐭𝐨 𝐭𝐡𝐞 𝐖𝐇𝐎 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬: https://lnkd.in/ep6G9YKU

Boston University researchers are invited to learn more about the transformative funding opportunities available through the Advanced Research Projects Agency for Health (ARPA-H), a crucial initiative founded by President Joe Biden in 2022. ARPA-H has already committed over $1 billion to projects addressing some of the most urgent challenges in health and medicine, from cancer therapies and tissue regeneration to infectious disease control and #healthcare access. In support of these ambitious goals, ARPA-H Deputy Director Tyler Best, from the Health Science Futures Mission Office, will visit BU on October 28 to share insights into the agency’s funding strategies, priorities, and current opportunities for the BU research community. Best will highlight the agency’s focus on “high-risk, high-payoff” projects designed to tackle complex health problems that other sectors may not readily address. During his visit, Best will discuss ARPA-H’s unique approach to innovation, emphasizing its mission to achieve not just incremental advancements but radical solutions that drive equitable health outcomes for all Americans. With a strong commitment to addressing health disparities, ARPA-H programs are focused on breakthroughs that will serve underserved and underrepresented communities. Through initiatives like the Emerging Health Innovators (EHI), the agency is engaging early-career researchers and community health centers across diverse networks to reshape the health research landscape. As BU researchers consider applying, Best advises asking questions that probe the impact and transformative potential of their projects: “Is this a problem worth solving? Why now? And how could ARPA-H’s involvement unlock unprecedented advancements?” 🔬 🌟 ➡️ http://spr.ly/6007qAZfb

ARPA-H Director Dr. Renee Wegrzyn launched the groundbreaking 100M Advanced Research Projects Agency for Health (ARPA-H) #SprintForWomensHealth alongside First Lady Dr. Jill Biden and the Gender Policy Council. This sprint marks a significant step forward in advancing the White House Initiative on Women’s Health Research, aimed at tackling pressing challenges in women’s health. Watch the historic announcement here: https://lnkd.in/g5Hw3TRu   With a focus on advances in high-potential, high-impact biomedical and health research that cannot be readily accomplished through traditional research or commercial activity, ARPA-H is addressing data gaps, and tackling diseases uniquely impacting women. The ARPA-H Sprint is poised to revolutionize women's health outcomes. With a commitment to leveraging $100 million in public funding, the Sprint for Women’s Health is set to boost research and development in this continually underfunded space.    Dr. Wegrzyn emphasizes, “as a woman, and as the Inaugural Director of ARPA-H, I know first-hand that prioritizing health for the women of our nation that represent more than half of our population can wait no longer.”   But what exactly is ARPA-H and why was it started? Here's what you need to know:   🔬 ARPA-H is a funding agency driving high-impact biomedical research for equitable health solutions.  🌟 Established by President Biden to accelerate biomedical breakthroughs.  💡 Focuses on breakthrough technologies for a broad range of health challenges.  🩺 Not disease-specific, aiming to revolutionize health solutions for all.  🔍 Independent but collaborative, drawing on NIH's expertise while maintaining autonomy.   WHAM is thrilled that Dr. Wegrzyn will be a keynote speaker at the upcoming WHAM forum in April in Washington DC. We look forward to hearing her insights as we bring together leaders across the ecosystem to implement ambitious, actionable plans to accelerate women’s health research and investment.   We invite you to support WHAM’s Initiatives by signing up for the #3Not30 Initiative to increase funding for research and innovations, improve access and diversity in clinical trials and mine the data.   Join the 3Not30 Initiative and receive critical updates on women’s health here: https://lnkd.in/gPkGUjbu   #ARPAH #SprintForWomensHealth #WHAMNow #WomenInSTEM #WomensHealth #HealthcareInnovation #Collaboration

📅 TOMORROW to 27 August | Online Do you work on #health #CohortStudies in Australia? Join us in 3 workshops to expand our #HeSANDA activity & co-design new projects to build #research #data #infrastructure for the community > https://ow.ly/6amE50SzfTA Our HeSANDA (Health Studies Australian National Data Asset) activity is building national infrastructure to allow researchers to share and access data from health studies. In these workshops, you'll be able to co-design the scope of a new set of HeSANDA projects for cohort studies: 1️⃣ overview and objectives – 2 to 4 pm (AEST), Tuesday 30 July 2️⃣ scope and partnerships – 2 to 4 pm (AEST), Thursday 15 August 3️⃣ review and next steps– 2 to 4 pm (AEST), Tuesday 27 August. 🔗 Register now to join all 3 workshops > https://ow.ly/6amE50SzfTA ⚕️ HeSANDA is a foundational component of the ARDC’s health infrastructure portfolio – the People Research Data Commons, which is addressing Australia’s core digital health data challenges – and aims to make data from health studies discoverable to the broader research community. Register your interest > https://ow.ly/RbM650SzfTz

NIHR awards nearly £17 million for global health research projects The NIHR has awarded nearly £17 million to four new global health research projects. The projects aim to carry out targeted research to prevent, treat and manage multiple long-term conditions (MLTC) in low and middle income countries (LMICs).  The new awards range between £3 million and £5 million over three to five years. They have been made through the NIHR's Research on Interventions for Global Health Transformation (RIGHT) programme. The RIGHT programme funds interdisciplinary applied health research in LMICs.  In 2020, NIHR published its Strategic Framework for Multiple Long-Term Conditions (Multimorbidity) MLTC-M Research. This highlighted MLTC/multimorbidity as an area of strategic priority for NIHR. To continue to build on this area of strategic focus, the NIHR launched a sixth RIGHT call. The focus is on intervention and strategies for improved prevention, treatment and management of multiple long-term conditions. The terms ‘multiple long-term conditions’ or ‘multimorbidity’ refer to the existence of two or more long-term conditions in a single individual. There is international recognition that MLTCs are an increasing global health burden. In LMICs, there is a lack of evidence on interactions between common conditions, and how services can best be integrated. Many LMICs face the additional challenges of under-resourced healthcare systems, and limited health infrastructure. https://lnkd.in/eMpjBcz9

Addressing the Challenge of Digitalization Resistance in Public Health Agencies Our research paper titled 'Overcoming Resistance: Understanding the Dynamics of Digital Transformation in Public Health' has laid the foundation for tackling this critical issue. Presented at the 2024 European Conference on Information Systems in Paphos, our study identifies 33 key factors influencing the acceptance or resistance to digitalization in public health institutions. Based on a series of interviews spanning over two years within the EVALDIGE and REDIGE projects, these factors provide valuable insights into fostering acceptance or managing resistance. Our next steps involve validating these findings and assessing their impact on digitalization efforts. For those interested in learning more, you can access the full article here: https://lnkd.in/ed793e_d Thank you, Anna Lina Wolf, Melina S. and Torsten Eymann for the efficient and pleasant collaboration. Research Group Digital Health, FIM Forschungsinstitut für Informationsmanagement, Doreen Schick, Maria Neubauer

📅 30 July, 15 August and 27 August | Online Do you work on #health #CohortStudies in Australia? Join us in 3 workshops to expand our #HeSANDA activity and co-design new projects to build #research #data #infrastructure for the community > https://ow.ly/TL3B50SzfG8 Our HeSANDA (Health Studies Australian National Data Asset) activity is building national infrastructure to allow researchers to share and access data from health studies. In these workshops, you'll be able to co-design the scope of a new set of HeSANDA projects for cohort studies: 1️⃣ overview and objectives – 2 to 4 pm (AEST), Tuesday 30 July 2️⃣ scope and partnerships – 2 to 4 pm (AEST), Thursday 15 August 3️⃣ review and next steps – 2 to 4 pm (AEST), Tuesday 27 August. 🔗 Register now to join all 3 workshops > https://ow.ly/TL3B50SzfG8 ⚕️ HeSANDA is a foundational component of the ARDC’s health infrastructure portfolio – the People Research Data Commons, which is addressing Australia’s core digital health data challenges – and aims to make data from health studies discoverable to the broader research community. Register your interest > https://ow.ly/hz9750SzfGb

Fogarty International Centre Grant for Mobile Health: Technology and Outcomes in Low- and Middle-Income Countries (mHealth) The grant supports exploratory and developmental research to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs). https://lnkd.in/dqd_xS7Z #africa #funding #mhealth